1 / 22

Cancer cachexia syndrome

Cancer cachexia syndrome. นพ.บูรพา ปุสธรรม นพ.มณฑล ว่องวัณดี 2/3/50. Scope. Introduction Pathogenesis Conventional management Novel therapy. Introduction. Cachexia : Greek word Kakos : bad Hexis : condition Characteristics Weight loss Lipolysis Muscle wasting Anorexia

Download Presentation

Cancer cachexia syndrome

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Cancer cachexia syndrome นพ.บูรพา ปุสธรรม นพ.มณฑล ว่องวัณดี 2/3/50

  2. Scope • Introduction • Pathogenesis • Conventional management • Novel therapy

  3. Introduction • Cachexia : Greek word • Kakos : bad • Hexis : condition • Characteristics • Weight loss • Lipolysis • Muscle wasting • Anorexia • Chronic nausea • Asthenia • Anemia • Electrolyte and water abnormalities • Psychological distress

  4. Introduction • Diagnostic criteria for cachexia • Unintentional weight loss (≥ 5%) • BMI • < 20 in those aged < 65 yrs • < 22 in those aged ≥ 65 yrs • Albumin < 3.5 g/dl • Low fat-free mass (lowest 10%) • Evidence of cytokine excess (eg, elevated C-reactive protein)

  5. Introduction

  6. Introduction • Cancer cachexia • 80 % of advance disease • Unclear underlying pathophysiologic mechanism • Poor prognostic factor • Differ from other condition • Starvation • Dehydration • Sarcopenia

  7. Introduction • Cachexia VS anorexia (starvation) • Body composition • Cachexia : loss of fat and skeletal muscle prior decrease food intake, reserve non-muscle protein • Anorexia : loss of fat but small amount of muscle, after decrease food intake • Weight loss • Cachexia : complex metabolic events • Anorexia : simple nutritional deficiency • Treatment • Cachexia : multiple aspect • Anorexia : treatable by protein-calorie supplementation

  8. Introduction

  9. Introduction • Factors contributing for cancer cachexia • Host-related • Humeral factors • Treatment factors • Chemotherapy : mucositis, nausea, vomitting, diarrhea, taste alteration • Radiotherapy : enteritis, diarrhea, decrease saliva • Surgery : malabsortion due to gactrectomy, short bowel syndrome, pancreatic resection • Tumour-related • Tumour mediator • Mechanical problem • GI tract malignancy

  10. Pathogenesis • Humeral factor • TNF-α • Suppress lipoprotein lipase activity • Proteolytic activity • Apoptotis of skeletal muscle • Increase level of CRH and leptin • Interleukin-1 • Blocking neuropeptide Y • Increase level of CRH and leptin

  11. Pathogenesis • Humeral factor • Interleukin-6 • Activation of ubiquitin ligase-dependent preteosome pathway • Leukemia inhibitor factor (LIF) • Increase leptin • Ciliary neurotropic factor • Compose from IL-6 and LIF • Potent cachectic effect • Acute-phase protein response

  12. Pathogenesis • Humeral factor • Interferon-γ (IFN-γ) • Biologic activity overlap with TNF • Monoclonal Ab against IFN-γ could reverse wasting syndrome • Anti-cachetic mediator • Interleukin-4, interleukin-10, interleukin-13 • Soluble receptor for TNF and IL-6

  13. Pathogenesis • Tumour mediator • Lipid mobilizing factor(LMF) • Induce lipolysis • Correlate with weight loss • Proteolysis inducing factor(PIF) • Induce protein degradation • Decrease protein systhesis • May increase cytokines and acute phase protein

  14. Pathogenesis • Tumour mediator • Anemia inducing substance(AIS) • Decrease osmotic resistance and deformability • Increase fragile • Alter energy metabolism • Tumour product? • Induce uncoupling protein(UPC) • UPC 3 : brown adipose tissue and skeletal muscle • Decrease ATP production • Increase heat production

  15. Pathogenesis

  16. Pathogenesis

  17. Pathogenesis • Glucose homeostasis • Increase gluconeogenesis • Muscle and fat breakdown • Increase glycolysis from muscle and tumour • Increase lactate production • Elevation of cori cycle activity • 300 kcal/day of energy loss • Glucose intolerance • Insulin resistance • Increase counter regulatory hormone • Decrease muscle glucose uptake

  18. Pathogenesis

  19. Pathogenesis • Protein metabolism • Increase muscle catabolism • Decrease muscle protein synthesis • Muscle wasting : asthenia • Increase tumour protein synthesis • Increase liver protein synthesis • Acute phase protein

  20. Pathogenesis • Lipid metabolism • Increase lipolysis • Decrease lipogenesis • Profound loss of adipose tissue • Decrease lipoprotein lipase • Decrease clearance of triglyceride • Hypertriglyceridemia • Low LDL, HDL

  21. Pathogenesis

More Related